The effects of N-[2-(methylamino)ethyl]-5-isoquinolinesulfonamide (H-8) and 1-(5-isoquinolinesulfonyl)-2-methylpiperazine (H-7) on the growth of P388 and its multidrug-resistant (MDR) variants were examined with the objective of assessing the possible changes in cyclic nucleotide-dependent protein kinases and protein kinase C-mediated pathways associated with MDR. H-8, an inhibitor of cyclic neuclotidedependent protein kinases, inhibited the growth of the parental P388 murine leukaemic cells, but not that of MDR variants up to 200ylM. However the growth of both drug-sensitive and resistant cell lines were uniformly inhibited by H-7. Both the cytotoxic and cytokinetic results revealed that the growth-inhibition by H-8 of P388 cells is mainly due to a blockade of cell-cycle progression rather than due to a killing of cells. The degree of resistance to H-8 was directly proportional to their extent of resistance to vincristine, adriamycin, and 4'-demethylepipodophyllotoxin-9-(4,6-0-ethylidene)-p-D-glucopyranoside and to that of the expression of P-glycoprotein. These findings raised the possibility that P-glycoprotein might play a role in the cross-resistance to H-8. To test the hypothesis, we examined the effect of H-8 on the binding of 3H-vincristine to membrane fraction isolated from P388/VCR-600 cells and on the enhancement of cytotoxicity to anticancer drugs in MDR cells. H-8 did not have any influences on these reactions. Thus, the cross-resistance to H-8 may be mediated through a mechanism different from an overexpression of P-glycoprotein. Although cyclic AMP dependent protein kinase (A-kinase) activity was 1.77-fold increased in P388/VCR-600 cells, H-8 inhibited A-kinase activity of both P388/VCR-600 and P388 cells in a similar rate. There was no detectable cyclic GMP dependent protein kinase activity in these cell lines. These data suggest that the differential effect of H-8 on the proliferation of these cell lines may be mediated through an inhibition of one or more targets other than these protein kinases.
Multidrug resistance (MDR) is frequently characterised by diminished drug accumulation in resistant cells compared to their drug-sensitive parental cells (Inaba & Johnson, 1977; Tsuruo et al., 1982) . Concomitant overexpression of a 150-180 kDa surface membrane glycoprotein (P-glycoprotein) usually correlates with MDR (Juliano & Ling, 1976; Beck et al., 1979; Safa et al., 1986; Cornwell et al., 1986) . Cells selected in vitro with MDR phenotype are also reported to be significantly altered in their growth characteristics such as tumorigenicity and metastatic potential (Biedler et al., 1975; Mirski et al., 1987) . Although MDR is associated with a change in the expression of epidermal growth factor receptor (Zuckier & Tritton, 1983; Meyers et al., 1986; Vickers et al., 1988) and in several enzyme activities (Batist et al., 1986; Deffie et al., 1988) , biochemical and molecular bases of the change in the growth characteristics associated with MDR are not clearly established.
Although the molecular function of P-glycoprotein is not fully understood, an increasing body of evidence suggests that P-glycoprotein is a binding protein for chemotherapeutic agents such as vinblastine (Cornwell et al., 1986; Safa et al., 1986) , has an ATPase activity , could act as a pump molecule (Gerlach et al., 1986; Gros et al., 1986; Chen et al., 1986) , and transport antitumour agents outside the cells. It has been proposed that MDR modulators such as verapamil and trifluoperazine act by competitive inhibition of drug binding to P-glycoprotein on the plasma membrane (Cornwell et al., 1986; Naito et al., 1988) and subsequent blocking of drug efflux from the cell. Thus, in order to identify if P-glycoprotein is involved in the crossresistance to a drug, it is a good tool to examine the effect of such drug on the binding of 3H-daunomycin or3H-vincristine to plasma membrane fraction isolated from MDR cells which contain P-glycoprotein.
Isoquinolinesulfonamide derivatives, which were synthesised and characterised by Hidaka and coworkers (1984) , inhibit several protein kinases to a different extent. N-[2-(methylamino) ethyl]-5-isoquinolinesulfonamide (H-8) has the highest affinity to cyclic nucleotide dependent protein kinases and inhibits these enzyme activities effectively. 1-(5-Isoquinolinesulfonyl)-2-methylpiperazine, referred to H-7 is the most potent inhibitor of Ca2+-phospholipid-dependent protein kinase (protein kinase C) among the derivatives tested. In the process of screening to identify drugs which reverse MDR, we tested isoquinolinesulfonamide derivatives and found that H-8 itself inhibited the growth of drug-sensitive parental cells whereas MDR cells were very resistant to the growth-inhibitory effect of H-8. In contrast to H-8, H-7 inhibited the growth of both drug-sensitive and resistant P388 cells. To determine if the resistance to H-8 observed in MDR P388 cells could be due to an overexpression of P-glycoprotein and a decreased accumulation of H-8, we assessed the effect of H-8 on the binding of 3H-vincristine to membrane fraction isolated from P388/VCR-600 cells and on the enhancement of sensitivity to anti-tumour drugs in MDR cells. Our results show that H-8 does not have any effect on these reactions, suggesting that the resistance to H-8 is mediated through a mechanism different from an overexpression of P-glycoprotein.
Materials and methods

Chemicals
Vincristine sulfate was purchased from Shionogi Ltd, Osaka, Japan and dissolved with methanol acidified with sulfuric acid at pH 4.3. Adriamycin was purchased from Kyowa Hakko Ltd, Tokyo, Japan. 4'-Demethylepipodophyllotoxin-9-(4,6-O-ethylidene)-p-D-glucopyranoside (VP-16) was purchased from Bristol Myers. H-7 and H-8 were purchased from Seikagaku Kogyo, Tokyo, Japan and dissolved with distilled water and stored at 4C at the concentration of 10 mM. All these drugs were sterilised through a 0.2 ftm Corning filter. Adenosine 3':5'-cyclic monophosphate (cAMP), guanosine 3':5'-cyclic monophosphate (cGMP), Kemptide (Maller et al., 1978) were purchased from Sigma. 3H(-G)-vincristine (7.4 Ci mM '), '25I-labelled F(ab')2 fragment of sheep anti-mouse IgG, and [j-32P]ATP (3,000 Ci mmol1') were purchased from Amersham. C219 monoclonal antibody was kindly provided from Dr V. Ling (Ontario Cancer Research Institute, Toronto, Canada).
Cell lines and chemosensitivity P388/VCR cells developed as described previously (Ido et al., 1986) . P388/VCR was maintained in humidified atmosphere of 5% CO2 and 95% air in RPMI-1640 medium supplemented with 10% foetal bovine serum and 20pM 2-mercaptoethanol (growth medium) without vincristine. P388/VCR was stable for more than 2 years. P388/VCR-600 was developed by treating P388/VCR cells with increasing concentration of vincrinstine and now this cell line is about 200-times resistant to vincristine and maintained with an intermittent exposure to 400 nM vincristine. The growth-inhibitory effect of drugs was assessed as described previously (Ido et al., 1987) .
Cytosol and plasma membrane preparation The procedure for isolation of plasma membrane from P388/ VCR-600 cells is as follows. Cells were harvested at logarithmic growth phase and washed three times with phosphatebuffered saline (0.8% NaCl/0.115% Na2HPO4/0.02% KH2 P04/0.02% KCI) (PBS). All subsequent steps were carried out at 4°C. The cells were resuspended in lysis buffer (50 mM Hepes, pH 7.5/4 mM EDTA/2 mM EGTA/10% ethylene glycol/0.25 M sucrose/I mM dithiothreitol/0.2 mM phenylmethylsulfonyl fluoride/l sg ml-I leupeptin) to a concentration of about 1 x 10' cells per ml and homogenised with 3,000 r.p.m.
5 min using a motor-driven teflon-glass homogeniser. Cell homogenate was centrifuged at 4,000 g for 10 min. The supernatant was centrifuged at 100,000 g for 60 min. The supernatant was used as cytol and the pellet was either resuspended in a 0.1% Triton X-100 in lysis buffer or resuspended in 16% sucrose in 5 mM Tris-HCl, pH 7.5, overlaid on 32% sucrose in 5 mM Tris-HCl, pH 7.5, and centrifuged at 100,000 g for 60 min. The membrane fraction at the interface between 16 and 32% sucrose was used as a membrane fraction. Protein concentration was determined with Bio-Rad protein assay system. Western blotting Sodium dodesyl sulfate (SDS)-polyacrylamide gel electrophoresis was performed according to slight modification of the method of Laemmli et al. (1970) . Protein profiles were electroblotted onto nitrocellulose filter paper. The method used was essentially that of Towbin et al. (1979) . Blots were probed with C219 monoclonal antibody against P-glycoprotein, overlaid with 125I-labelled F(ab')2 sheep anti-mouse IgG, and binding was visualised by autoradiography.
Clonogenic assay Cells were prepared as described above, treated with various concentrations of H-8 for 72 h, after which cell suspension was more than 500 times diluted with growth medium with 1% methylcellulose and plated. The number of cells plated was adjusted to obtain approximately 200 colonies in the dish (Lux 5221) without H-8. After incubation for 1 week, colonies were counted using an inverted microscopy and the surviving fractions were calculated by dividing the number of colonies on the treated plates with the number of colonies on the untreated control plates. Cytokinetics For cytokinetic measurement, cells were incubated with or without 60 tiM H-8 for 48 h and washed twice with PBS, at which time cells were fixed with ethanol and processed as before (Higashigawa et al., 1989) by staining with a propidium iodide/RNAase and analysed on a Coulter EPICS-C flow cytometer.
Binding assay Binding of 3H-vincristine to membrane fraction was measured by filtration assay (Naito et al., 1988) . Plasma membrane fraction containing 20 gg of protein was incubated at 37°C with 100 nM 3H-vincristine and 3.3 mM ATP in 10 mM Tris-HCI (pH 7.5), 250 mM sucrose, and 5 mM MgCl2 with or without modifiers in a total volume of 100 JAl. After 60 min incubation, samples were collected and washed on glass fibre filter (LM1I1-10, Labo Science Co. Ltd, Japan) with iced PBS. The filters were dried and the radioactivity on each membrane filter was measured in a liquid scintillation counter.
Kinase assay
Cytosol and extracted membrane fraction were prepared as described above and used as enzyme solution. A-kinase activity and an inhibitory effect of H-8 were examined in a 50 gl of reaction mixture containing 50 mM morpholinopropanesulfonic acid (pH 7.0), 10 mM MgCl2, 0.25 mg ml-' bovine serum albumin, 100 mM Kemptide, 10 mM [y32P]ATP (300-600 c.p.m. pmol-'), enzyme, and 10IM cAMP with or without various concentrations of H-8. The reactions are initiated by the addition of ATP. Following incubation for 5 min at 30°C, the reaction was terminated by the addition of 100ly 37.5% trichloacetic acid and processed as described (Roskoski, 1983) . G-kinase activity was assayed as described (Inagaki et al., 1985) .
Results
Resistance to anticancer drugs Table I shows the sensitivity of P388, P388/VCR, and P388/ VCR-600 cells for vincristine, adriamycin, and VP-16. In comparison with the parental P388 cells, P388/VCR and P388/VCR-600 cells were 14.3 and 289.6-fold resistant to vincristine, respectively. These two cell lines showed crossresistance to adriamycin and VP-16 according to their extent of resistance to vincristine.
Western blotting
The expression of P-glycoprotein was examined in these cell lines to evaluate the mechanism of MDR phenotype. Membrane extracts from P388 cells, P388/VCR and P388/VCR-600 were electrophoresed on 7.5% SDS-polyacrylamide gels, and transblotted onto nitrocellulose membrane and reacted with C219 monoclonal antibody followed by the reaction with "25I-labelled F(ab')2 fraction of sheep antimouse IgG and visualised by autoradiography. As shown in Figure 1 , overexpression of 170 kDa protein was observed in P388/VCR and P388/VCR-600.
Effect of isoquinolinesulfonamide protein kinase inhibitors on the proliferation of cells The effect of H-7 and H-8 on the proliferation of P388 cells, P388/VCR and P388/VCR-600 was assessed by measuring the number of cells per well, colony-forming capacity, and DNA histograms following 48 h exposure to H-7 or H-8. As shown in Figure 2a , H-8 dose-dependently inhibited the growth of P388 cell line, however, P388/VCR-600 cell was quite resistant to H-8 up to 200 tLM. There was a significant The effect of H-8 on the binding of3H-vincristine to membrane vesicles Since P388/VCR and P388/VCR-600 overexpress P-glycoprotein which acts as a pump molecule and transports anticancer agents outside the cell, we initially predicted that P-glycoprotein should play an important role in the mechanism of cross-resistance to H-8. These predictions were tested by examining the effect of H-8 on the binding of 3H-vincristine to membrane fractions isolated from P388/VCR-600 cells. As shown in Figure 3 , the binding of 3H-vincristine to membrane fraction is inhibited in a dose-dependent manner by vincristine, adriamycin, or verapamil whereas H-8 had no effect at the concentration up to 100 riM.
A-kinase and G-kinase activities To determine if the cross-resistance to H-8 observed in P388/ VCR-600 cell is due to an increase in A-kinase or G-kinase activity, the enzyme activity of cytosol and membrane fraction from P388 and P388/VCR-600 cell lines was measured. Although A-kinase activity significantly increased in P388/ VCR-600 cells (Table III) , H-8 inhibited A-kinase activity of P388 and P388/VCR-600 cells in a similar rate (Figure 4 ). There was no detectable G-kinase activity in these cell lines. 
T3
Because the degree of resistance to H-8 is directly proportional to both the intensity of resistance to anticancer drugs such as vincristine, adriamycin, and VP-16 and the extent of P-glycoprotein expression, the mechanism of resistance to H-8 might be related to an amplification of a gene, the overexpression of which might be the result of its co-amplification with mdr (P-glycoprotein) gene.
H-7 and H-8 inhibit several protein kinases in a different extent. H-8 is reported to be the most potent inhibitor of cyclic nucleotide-dependent protein kinases and inhibits protein kinase C more weakly than H-7 and vice versa. We measured these kinase activities in these cell lines. Although A-kinase activity was about 1.77-fold higher in P388/VCR-600 cells than that in P388 cells, H-8 inhibited A-kinase activity or both cell lines in a similar rate. No detectable G-kinase activity was found in these cell lines. Therefore cross-resistance to H-8 may not be related to a change in A-kinase or G-kinase activity. Another explanation of this phenomenon is that H-8 may affect one or more targets unrelated to these protein kinases which could control regulatory pathways critical for the proliferation of the parental P388 cells but not for that of P388/VCR-600 cells.
From the data present here, it is tentatively concluded that the cross-resistance to H-8 observed in MDR variants of P388 cells is not due to an overexpression of P-glycoprotein or a change in A-kinase or G-kinase activity. Further studies are necessary to identify the cause of the resistance to H-8 in MDR cell lines.
